Clinical Trial Update: Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean Section [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports results from Phase 1 and Phase 2 studies evaluating whether combining oxytocin and misoprostol reduces blood loss during cesarea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• MISOPROSTOL (Misoprostol)
• Oxytocin (Oxytocin)

Snippet

Sponsor: Qazvin University Of Medical Sciences | Conditions: Post Partum Haemorrhage | Phase 1, Phase 2 | Status: COMPLETED